The Iceberg Theory — Fact or Fiction? Implication for Monitoring

  • S. A. Feldman


Paton and Waud (1), demonstrated an apparent excess of receptor sites for antagonist drugs which they proposed constituted a “Margin of Safety” for neuromuscular transmission. They suggested that in view of the reported vast excess of ACh released from the motor terminals up to 80% of the available ACh receptors on the post synaptic membrane had to be ‘occupied’ by non-depolarizing drug before the indirectly elicited twitch response was depressed. Waud and Waud (2) subsequently demonstrated that if a 50Hz tetanic stimulus was used the margin of safety was reduced from 80% to 50–60%. Complete ablation of the twitch response occurred when over 95% of the receptors were ‘occupied’.


Receptor Occupancy Neuromuscular Transmission Neuromuscular Blocking Agent Effect Compartment Antagonist Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paton, W.D.M., Waud, D.R. The margin of safety of neuromuscular transmission. J Physiol 1967;191:59–90.PubMedGoogle Scholar
  2. 2.
    Waud, D.R., Waud, B.E. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block Anesthesiology 1971;35:456–461.PubMedCrossRefGoogle Scholar
  3. 3.
    Waud, B.E., Waud, D.R. Physiology and pharmacology of neuromuscular blocking agents. In: Muscle Relaxants. Ed Katz, R.L. Monographs in Anesthesiology 1975;3:1–58. Publ Excerpta Medica, Amsterdam.Google Scholar
  4. 4.
    Feldman, S.A. Measurements of neuromuscular block. In: Measurements in Anaesthesia. Ed Spierdijk, J., Feldman, S.A., Leigh, J. 194;pg 36. Leiden University Press, Holland.Google Scholar
  5. 5.
    Bowman, W. C in Pharmacology of Neuromuscular Function. 1990:170–171. Publ Wright, London.Google Scholar
  6. 6.
    Armstrong, D.L., Lester, H.A. The kinetics of d-tubocurare action and restricted diffusion within the synaptic cleft. J Physiol 1979;294:365-PubMedGoogle Scholar
  7. 7.
    Colquhoun, D. On the principles of postsynaptic action of neuromuscular blocking agents. In Receptors. Ed O’Brien, R.D. 1979;93:112. Plenum Press. New York.Google Scholar
  8. 8.
    Haxby, E.J., Hood, J.R., Gopinath, S., Feldman, S.A. Mivacurium priming intervals. British Journal of Anaesthesia 1994 73:724.Google Scholar
  9. 9.
    Hood, J.R., Campkin, N.T.A., Feldman, S.A. bioassay of mivacurium — to be published in Anaesthesia 1994.Google Scholar
  10. 10.
    Campkin, N.T.A., Hood, J.R., Fauvel, N.J., Feldman, S.A. The effect of residual receptor occupancy on sensitivity to repeated vecuronium. Anaesthesia 1993;48:572–575.PubMedCrossRefGoogle Scholar
  11. 11.
    Felldnman, S.A., Hood, J.R., Campkin, N.T.A., Rehm, S. Sensitivity to second dose of mivacurium — to be published in Anaesthesia 1994 49:671–674.Google Scholar
  12. 12.
    Feldman, S.A. Biophase binding — its effect on recovery from non-depolarizing neuromuscular block. Anaesth Pharm Rev 1993;1:81–88.Google Scholar

Copyright information

© Springer Japan 1995

Authors and Affiliations

  • S. A. Feldman
    • 1
  1. 1.Magill Department of Anaesthetics, Chelsea and Westminster HospitalLondonUK

Personalised recommendations